Primary biliary cirrhosis (PBC) is a multisystem disease, characterized by cholestatic jaundice, and an association with other 'collagen' diseases as described by Sherlock & Scheuer (1973) and Schaffner (1979) . The diagnosis is based on a positive mitochondrial antibody (MA) test, increased levels of serum IgM and a diagnostic or compatible liver biopsy (Sherlock & Scheuer 1973) .
The mixed connective tissue disease syndrome (MCTD) characteristically affects mainly females and has clinical features of systemic lupus erythematosus (SLE), systemic sclerosis and polymyositis (Ellery 1972 , Sharp et al. 1972 , Bresnihan et al. 1977 . The serologic findings are a high titre to antinuclear antibody (ANA) in a speckled pattern and a-high haemagglutination titre of antibody to extractable nuclear antigen (ENA). Invariably this antibody is directed against the RNase-sensitive ribonucleoprotein antigen (RNP) and not against the RNaseresistant Sm antigen (Sharp et al. 1976) .
This report describes a young woman who presented with PBC and subsequently developed polymyositis and two years later rapidly progressive systemic sclerosis. One other case has previously been reported (Uhl et al. 1974) . Both the myositis and the systemic sclerosis responded rapidly to treatment with prednisolone. The clinical features of this syndrome resembled those of MCTD but the autoantibody profile was different from that previously described for MCTD (Ellery 1972 , Sharp et al. 1972 , 1976 , Bresnihan et al. 1977 . It normal. An autoantibody screen revealed a strongly positive mitochondrial antibody, but smooth muscle antibodies (SMA), anti-nuclear antibodies (ANA), and rheumatoid factor (RF) were not detected. Creatinine phosphokinase (CPK) levels were increased to 3300 iu/l (normal 4-50), and electromyography showed motor units with brief, polyphasic low amplitude waves. Triceps muscle biopsy showed variability of muscle size, muscle necrosis, macrophage infiltration, endomysial inflammation and perivasculitis. A diagnosis of polymyositis was made, and prednisolone therapy was commenced (60 mg/day). Muscle power rapidly improved and the CPK levels fell to 150 iu/l. The prednisolone was stopped after 3 months, and over the following 2 years the patient remained stable, although weak. In early 1980 the patient gave a 2-week history of joint pain, finger swelling, weight loss of 4 kg, fever and increased stool frequency. On examination her fingers were swollen, and the skin overlying the hands and wrists was tight and thickened. There was no telangiectasis, and a Schirmer's test indicated normal tear production.
A chest X-ray was normal, and a bone survey indicated the presence of calcinosis affecting the fingers, elbows and knees. Faecal fat excretion was breath test indicated small intestinal bacterial overgrowth. A barium swallow showed abnormal oesophageal motility, and barium follow-through examination showed features of malabsorption, with shortening and thickening of the small bowel loops. An attempted peroral jejunal biopsy failed. Lung function tests indicated reduced lung volumes, and impaired gas transfer (TL CO 8 ml/mmHg, expected value 19.5). Serum creatinine and urea and electrolytes were normal. In addition to a strongly positive MA, the ANA was positive (1: 640). The ENA was weakly positive (1: 15); the RNase sensitive component being positive for ribonucleoprotein (RNP) antibody by precipitation. It was not positive for the Sm antibody. DNA binding was absent and the rheumatoid factor (RAHA) was negative. Complement levels were in the low normal range, C3 115 mg/100 ml (normal 95-205) and C4 28 mg/100 ml (normal 20-60), while there was evidence of complement activation as the C3d was II mg/100 ml (normal 1.5-3) and C3b 14 mg/100 ml (normally absent).
The intestinal bacterial overgrowth responded to treatment with metronidazole, and the arthralgia responded to indomethacin. Ten days after starting the analgesia the patient presented with a haematemesis due to superficial gastritis. The indomethacin was discontinued and the arthralgia recurred. Prednisolone in a dose of 60 mg daily led to an immediate fall in temperature and rapid relief of the arthralgia. Within a week the finger swelling resolved, and there was marked improvement of the sclerodermatous skin changes of the hands and wrists. The complement levels returned to normal after 3 weeks and the ANA titre fell to 1: 160. A repeat barium meal and follow-through, performed 3 months after presentation, showed a normal small bowel pattern with normal transmit time. A xylose tolerance test was normal.
Discussion PBC is associated with other 'collagen' diseases, especially Sjogrens syndrome, scleroderma, rheumatoid arthritis and Hashimoto's thyroiditis (Sherlock & Scheuer 1973 , Schaffner 1979 . The scleroderma tends to be mild, affecting the hands and occasionally the oesophagus, but rarely the bowel, lungs, heart or kidney. According to Clarke et al. (1978) , the sclerodermatous skin changes may be associated with calcinosis, Raynaud's phenomenon and telangiectasis (CRST syndrome).
The patient reported in this paper presented with PBC, and later developed polymyositis, followed by systemic sclerosis affecting the skin, oesophagus, intestine and lungs. The systemic sclerosis presented acutely and resolved dramatically when immunosuppressive doses of prednisolone were introduced. The syndrome of PBC, polymyositis and systemic sclerosis has been reported on a previous occasion by Uhl et al. (1974) . The combination of these three 'autoimmune' diseases resembles the MCTD syndrome as described by Ellery (1972) , Sharp et al. (1972) and Bresnihan et al. (1977) . This occurs predominantly in women, and is characterized by features of SLE, polymyositis and systemic sclerosis (Ellery 1972 , Sharp et al. 1972 , Bresnihan et al. 1977 .
Like the patient in this report, onset of the disease is often acute and presents with nondeforming arthralgia, swelling of the fingers, thickening and tightening of the skin and features of a proximal myopathy. Ellery (1972) states that renal and cardiac functions are preserved, and the arthralgia, fever, myopathy, finger swelling and sclerodermatous skin changes respond dramatically to high-dose corticosteroids.
As part of the diagnostic criteria for MCTD, Sharp et al. (1972 ), Bresnihan et al. (1977 and Ellery (1972) report the presence of ENA in high titre, and the ANA often has a speckled appearance. However, in our patient, ENA was present in low titre, and the ANA although strongly positive was not speckled. Antibody to RNP was positive and antibody to the Sm antigen absent as defined in MCTD (Sharp 1976) . In this patient with PBC, as in the only other one so far reported (Uhl et al. 1974) , the presentation, clinical signs and response to treatment indicate that PBC can be rarely associated with a clinical syndrome similar to MCTD as presently described, with PBC replacing SLE in the triad of coexisting collagen diseases. Although the clinical syndromes are similar, the autoantibody profiles differ. This could suggest that the ENA in high titre and speckled ANA may only reflect the coexisting autoimmune disease and not be pathognomonic of MCTD as suggested by Reichlin (1976) who considers MCTD as a variant of SLE. It is interesting to note that Sharp et al. (1976) describe 6 patients in their series with overlapping features of scleroderma and polymyositis who had negative or low titre tests for ENA, RNP and Sm antibodies.
The findings in our patient and that of Uhl et al. (1974) would suggest that from a clinical standpoint MCTD is truly a syndrome and the component 'autoimmune' diseases should include primary biliary cirrhosis. Furthermore, it emphasizes the difficulty in making rigid differences between groups of patients who probably have different facets of a syndrome with a wide spectrum.
